Pharmakovigilanz

08. und 09. Oktober 2018, Fachtagung
10. Oktober 2018, Workshop
Köln

PDF Agenda Save the date Newsletter

Intro / Agenda / Referenten / Veranstaltungsort / Information Center / Präsentationen

Referenten

Dr. Boris Thurisch
Leiter Geschäftsfeld Arzneimittelsicherheit/ Pharmakovigilanz, Bundesverband der Pharmazeutischen Industrie e.V. (BPI)

Dr. Kimberley Sherwood
Senior Pharmacovigilance Expert, Bonn

Dr. Stefan Kähler
Executive Director, Global Senior Lead Safety Scientist & EEA-QPPV, Celgene Europe Ltd.

Dr. Tanja Peters
Deputy EU-QPPV & Head PV Intelligence, Boehringer Ingelheim Pharma GmbH & Co. KG

Dr. med. Uwe Gudat
Head of Clinical Safety & Pharmacovigilance, Clinical Safety & Pharmacovigilance, Fresenius Kabi SwissBioSim GmbH

Julia Sämann
Head of Pharmacovigilance, CO.DON AG

Dr. Nicole Lang
MD, Sr. Director, PhV TA Group Leader, Respiratory & Biosimilars, Global Patient Safety & Pharmacovigilance, ratiopharm GmbH

Dr. Andreas Iwanowitsch
Head Global Pharmacovigilance Unit, EU QPPV Backup, STADA Arzneimittel AG

Dr. med. Heinz Weidenthaler
Director Pharmacovigilance, QPPV, Bavarian Nordic GmbH

Dr. Nicole Rämsch-Günther
Senior Expert for Medical Devices, Bonn

Dr. Tanja Fahlbusch
Senior Expert International Pharmacovigilance Process Liason, F. Hoffmann-La Roche AG

Dr. Dr. Adem Koyuncu
Rechtsanwalt und Arzt, Kanzlei Covington & Burling LLP, Frankfurt/Brüssel

Dr. Arndt Pannenbecker
Partner, AVANTCORE Rechtsanwälte Partnerschaft mbH

Dr. med. Simone Breitkopf
Senior Medical Expert

Dr. Martin Huber
Senior Pharmacovigilance Expert, Senior Pharmacovigilance Expert

Dr. Renz Streit
Referat Pharmakovigilanz I, Paul-Ehrlich-Institut